NCT02924064View on ClinicalTrials.gov

Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 25, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Teneligliptin 20mg

DRUG

Placebo

DRUG

Metformin ≥ 1000 mg

Trial Locations (1)

Unknown

Investigational center, Beijing

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY